Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baoli Hu

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Research Square|January 9, 2026
Erythrocyte-microglia crosstalk contributing to sex differences in pediatric brain tumorigenesisBaoli Hu
Cancer Research|September 19, 2007
Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMXBaoli Hu, Daniele M Gilkes, Jiandong Chen
Frontiers in Immunology|January 26, 2023
Pre-clinical models for evaluating glioma targeted immunotherapiesStephen C Frederico, Xiaoran Zhang, Baoli Hu, et al.
Journal of Virological Methods|March 26, 2004
Development of a novel recombinant adenovirus containing gfp-zeocin fusion expression cassette for conditional replication in p53-deficient human tumor cellsBaoli Hu, Mallam Nock Joshua, Changyuan Dong, et al.
Antioxidants & Redox Signaling|May 11, 2023
Tumor Niches: Perspectives for Targeted Therapies in GlioblastomaRashmi Srivastava, Meghana Dodda, Han Zou, et al.
Cancers|March 14, 2020
Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in MedulloblastomaHan Zou, Brad Poore, Alberto Broniscer, et al.
Cancer Chemotherapy and Pharmacology|September 29, 2017
miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1Haifeng Zhang, Baoli Hu, Zuopei Wang, et al.
Artificial Cells, Nanomedicine, and Biotechnology|August 14, 2019
Circular RNA ZFR accelerates non-small cell lung cancer progression by acting as a miR-101-3p sponge to enhance CUL4B expressionHaifeng Zhang, Xiaolong Wang, Baoli Hu, et al.
Cancer Biology & Therapy|October 12, 2017
LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4Baoli Hu, Haifeng Zhang, Zuopei Wang, et al.
The Journal of Biological Chemistry|August 15, 2006
MDMX overexpression prevents p53 activation by the MDM2 inhibitor NutlinBaoli Hu, Daniele M Gilkes, Bilal Farooqi, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Research Square|January 9, 2026
Erythrocyte-microglia crosstalk contributing to sex differences in pediatric brain tumorigenesisBaoli Hu
Cancer Research|September 19, 2007
Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMXBaoli Hu, Daniele M Gilkes, Jiandong Chen
Frontiers in Immunology|January 26, 2023
Pre-clinical models for evaluating glioma targeted immunotherapiesStephen C Frederico, Xiaoran Zhang, Baoli Hu, et al.
Journal of Virological Methods|March 26, 2004
Development of a novel recombinant adenovirus containing gfp-zeocin fusion expression cassette for conditional replication in p53-deficient human tumor cellsBaoli Hu, Mallam Nock Joshua, Changyuan Dong, et al.
Antioxidants & Redox Signaling|May 11, 2023
Tumor Niches: Perspectives for Targeted Therapies in GlioblastomaRashmi Srivastava, Meghana Dodda, Han Zou, et al.
Cancers|March 14, 2020
Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in MedulloblastomaHan Zou, Brad Poore, Alberto Broniscer, et al.
Cancer Chemotherapy and Pharmacology|September 29, 2017
miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1Haifeng Zhang, Baoli Hu, Zuopei Wang, et al.
Artificial Cells, Nanomedicine, and Biotechnology|August 14, 2019
Circular RNA ZFR accelerates non-small cell lung cancer progression by acting as a miR-101-3p sponge to enhance CUL4B expressionHaifeng Zhang, Xiaolong Wang, Baoli Hu, et al.
Cancer Biology & Therapy|October 12, 2017
LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4Baoli Hu, Haifeng Zhang, Zuopei Wang, et al.
The Journal of Biological Chemistry|August 15, 2006
MDMX overexpression prevents p53 activation by the MDM2 inhibitor NutlinBaoli Hu, Daniele M Gilkes, Bilal Farooqi, et al.
Pageof 7